Cargando…
Iatrogenic Creutzfeldt-Jakob Disease from Commercial Cadaveric Human Growth Hormone
Autores principales: | Appleby, Brian S., Lu, Mei, Bizzi, Alberto, Phillips, Michael D., Berri, Sally M., Harbison, Madeleine D., Schonberger, Lawrence B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647424/ https://www.ncbi.nlm.nih.gov/pubmed/23750511 http://dx.doi.org/10.3201/eid1904.121504 |
Ejemplares similares
-
Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment
por: Brown, Paul, et al.
Publicado: (2012) -
Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study
por: Cali, Ignazio, et al.
Publicado: (2018) -
Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging
por: Bizzi, Alberto, et al.
Publicado: (2020) -
Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease
por: Pascuzzo, Riccardo, et al.
Publicado: (2020) -
Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone
por: Cali, Ignazio, et al.
Publicado: (2015)